Inhibition of ATG-induced experimental transplantation tolerance with LS2616.
Olausson
M
M
Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.
Arvidsson
N
N
Lukes
D
D
Mjörnstedt
L
L
Qi
Z
Z
Ekberg
H
H
Gannedahl
G
G
Tufveson
G
G
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000494:pharmacology*; D016572:Cyclosporine / Q000008:administration & dosage; D004357:Drug Synergism; D005260:Female; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology; D006912:Hydroxyquinolines / Q000494:pharmacology*; D007108:Immune Tolerance / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous
D000276:Adjuvants, Immunologic; D000961:Antilymphocyte Serum; D006912:Hydroxyquinolines; D007166:Immunosuppressive Agents; C045282:roquinimex; D016572:Cyclosporine